112 related articles for article (PubMed ID: 9600629)
21. Anticancer Potential of β-Carboline Alkaloids: An Updated Mechanistic Overview.
Tshikhudo PP; Mabhaudhi T; Koorbanally NA; Mudau FN; Avendaño Caceres EO; Popa D; Calina D; Sharifi-Rad J
Chem Biodivers; 2024 Feb; 21(2):e202301263. PubMed ID: 38108650
[TBL] [Abstract][Full Text] [Related]
22. Effects of harmane and other β-carbolines on apomorphine-induced licking behavior in rat.
Farzin D; Haghparast A; Motaman S; Baryar F; Mansouri N
Pharmacol Biochem Behav; 2011 Apr; 98(2):215-9. PubMed ID: 21237191
[TBL] [Abstract][Full Text] [Related]
23. Noribogaine generalization to the ibogaine stimulus: correlation with noribogaine concentration in rat brain.
Zubaran C; Shoaib M; Stolerman IP; Pablo J; Mash DC
Neuropsychopharmacology; 1999 Jul; 21(1):119-26. PubMed ID: 10379526
[TBL] [Abstract][Full Text] [Related]
24. Effect of some beta-carbolines on phenylethylamine and apomorphine stereotypies in rats.
Kari I; Rapakko S; Airaksinen MM
Pharmacol Biochem Behav; 1980 Jun; 12(6):979-82. PubMed ID: 7190704
[TBL] [Abstract][Full Text] [Related]
25. Antiplatelet activity of beta-carboline alkaloids from Perganum harmala: a possible mechanism through inhibiting PLCgamma2 phosphorylation.
Im JH; Jin YR; Lee JJ; Yu JY; Han XH; Im SH; Hong JT; Yoo HS; Pyo MY; Yun YP
Vascul Pharmacol; 2009; 50(5-6):147-52. PubMed ID: 19073282
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the hallucinogenic indole alkaloids ibogaine and harmaline for potential immunomodulatory activity.
House RV; Thomas PT; Bhargava HN
Pharmacology; 1995 Jun; 51(1):56-65. PubMed ID: 7568345
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies.
Deecher DC; Teitler M; Soderlund DM; Bornmann WG; Kuehne ME; Glick SD
Brain Res; 1992 Feb; 571(2):242-7. PubMed ID: 1377086
[TBL] [Abstract][Full Text] [Related]
28. Discriminative stimulus control by the anxiogenic beta-carboline FG 7142: generalization to a physiological stressor.
Leidenheimer NJ; Schechter MD
Pharmacol Biochem Behav; 1988 Jun; 30(2):351-5. PubMed ID: 3174766
[TBL] [Abstract][Full Text] [Related]
29. Harmala alkaloids and related beta-carbolines: a myoclonic model and antimyoclonic drugs.
Pranzatelli MR; Snodgrass SR
Exp Neurol; 1987 Jun; 96(3):703-19. PubMed ID: 3495451
[TBL] [Abstract][Full Text] [Related]
30. Effects of beta-carboline alkaloids on the object recognition task in mice.
Moura DJ; Rorig C; Vieira DL; Henriques JA; Roesler R; Saffi J; Boeira JM
Life Sci; 2006 Oct; 79(22):2099-104. PubMed ID: 16904699
[TBL] [Abstract][Full Text] [Related]
31. Affinity of beta-carbolines on rat brain benzodiazepine and opiate binding sites.
Airaksinen MM; Mikkonen E
Med Biol; 1980 Dec; 58(6):341-4. PubMed ID: 6112290
[TBL] [Abstract][Full Text] [Related]
32. Biosensor based on inhibition of monoamine oxidases A and B for detection of β-carbolines.
Radulescu MC; Bucur MP; Bucur B; Radu GL
Talanta; 2015 May; 137():94-9. PubMed ID: 25770611
[TBL] [Abstract][Full Text] [Related]
33. Behavioral and biochemical evidence for serotonergic actions of tetrahydro-beta-carbolines.
Nielsen EB; White FJ; Holohean AM; Callahan PM; Appel JB
Life Sci; 1982 Nov; 31(22):2433-9. PubMed ID: 7154844
[TBL] [Abstract][Full Text] [Related]
34. Effect of Peganum harmala or its beta-carboline alkaloids on certain antibiotic resistant strains of bacteria and protozoa from poultry.
Arshad N; Zitterl-Eglseer K; Hasnain S; Hess M
Phytother Res; 2008 Nov; 22(11):1533-8. PubMed ID: 18814210
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae).
Bensalem S; Soubhye J; Aldib I; Bournine L; Nguyen AT; Vanhaeverbeek M; Rousseau A; Boudjeltia KZ; Sarakbi A; Kauffmann JM; Nève J; Prévost M; Stévigny C; Maiza-Benabdesselam F; Bedjou F; Van Antwerpen P; Duez P
J Ethnopharmacol; 2014 Jun; 154(2):361-9. PubMed ID: 24746482
[TBL] [Abstract][Full Text] [Related]
36. Antioxidative properties of harmane and beta-carboline alkaloids.
Tse SY; Mak IT; Dickens BF
Biochem Pharmacol; 1991 Jul; 42(3):459-64. PubMed ID: 1859459
[TBL] [Abstract][Full Text] [Related]
37. Interaction of carbolines and some GABA receptor ligands with the GABA and the benzodiazepine receptors.
Mousah H; Jacqmin P; Lesne M
J Pharmacol; 1986; 17(4):686-91. PubMed ID: 3031382
[TBL] [Abstract][Full Text] [Related]
38. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate.
Yang XM; Luo ZP; Zhou JH
J Pharmacol Exp Ther; 1989 Jul; 250(1):358-63. PubMed ID: 2545863
[TBL] [Abstract][Full Text] [Related]
39. Interaction of beta-carbolines with central dopaminergic transmission in mice: structure-activity relationships.
Pimpinella G; Palmery M
Neurosci Lett; 1995 Apr; 189(2):121-4. PubMed ID: 7609916
[TBL] [Abstract][Full Text] [Related]
40. Beta-carbolines, psychoactive compounds in the mammalian body. Part I: Occurrence, origin and metabolism.
Airaksinen MM; Kari I
Med Biol; 1981 Feb; 59(1):21-34. PubMed ID: 7022042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
